NOVAVAX INC (NVAX)

US6700024010 - Common Stock

4.6  +0.62 (+15.58%)

News Image
22 minutes ago - InvestorPlace

Morgan Stanley Is Pounding the Table on DoorDash (DASH) Stock

DoorDash stock is rising higher on Thursday after Morgan Stanley upgraded DASH shares and increased their price target for them.

News Image
33 minutes ago - InvestorPlace

Morgan Stanley Issues a Warning on Rivian (RIVN) Stock

Rivian stock is falling hard on Friday as RIVN investors react to a warning from Morgan Stanley and a weak EV production guidance for 2024.

News Image
an hour ago - InvestorPlace

NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute

Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi.

News Image
4 hours ago - Seeking Alpha

Novavax settles COVID-19 vaccine dispute with Gavi (NASDAQ:NVAX)

Novavax (NVAX) agrees to refund Gavi at least $475M in cash or vaccines to settle a dispute over a COVID-19 vaccine purchase agreement.

News Image
5 hours ago - The Motley Fool

Better Bull Market Buy: Novavax vs. Pfizer

Bull markets usually favor stocks with promising growth prospects.

News Image
5 hours ago - NOVAVAX, INC

Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) and Gavi, the Vaccine Alliance (Gavi) today announced they have reached a settlement related to the 2021 Advance...

News Image
2 days ago - Novavax, Inc.

Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its...

News Image
7 days ago - InvestorPlace

Get Rich Quick With These 3 Stocks to Buy Now

Although these market ideas are extremely speculative, their upcoming catalysts could make them stocks to buy now.

News Image
7 days ago - The Motley Fool

Where Will Novavax Be in 10 Years?

Without any windfalls on the horizon, times are dire for this biotech.

News Image
11 days ago - InvestorPlace

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.

News Image
11 days ago - BusinessInsider

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The unpredictable nature of the biotech industry, which frequently flirts with ...

News Image
17 days ago - The Motley Fool

3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market

Bull markets favor growth stocks so now could be the time for these players to shine.

News Image
19 days ago - The Motley Fool

Better Recovery Story Buy: Novavax vs. Teladoc

Both stocks have fallen more than 90% from their peak.

News Image
20 days ago - Seeking Alpha

Novavax-backed malaria shot shows 75% efficacy (NASDAQ:NVAX)

A malaria vaccine based on technology from Novavax (NVAX) shows promising results with a 75% efficacy rate in African children. Read more here.

News Image
21 days ago - Market News Video

NVAX March 22nd Options Begin Trading

News Image
21 days ago - The Motley Fool

Could Novavax Stock Help You Become a Millionaire?

Novavax aims to win with its coronavirus/flu vaccine candidate, now in clinical trials.

News Image
22 days ago - InvestorPlace

Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts

The Novavax layoffs are coming for 12% of the company's global workforce. However, NVAX stock itself could shock the market.

News Image
22 days ago - BusinessInsider

Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotechnology firm Novavax (NASDAQ:NVAX)– which specializes in developing...

News Image
22 days ago - Seeking Alpha

Novavax stock gains amid layoffs (NASDAQ:NVAX)

Novavax (NVAX) plans to cut 12% of its workforce to reduce expenses amid lower demand for COVID-19 products. Read more here.

News Image
22 days ago - The Motley Fool

3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts

If a trio of Wall Street analysts is correct, three lesser-known stocks could skyrocket in the new year.

News Image
24 days ago - The Motley Fool

1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell

This biotech isn't at the end of the road just yet, but don't bet on a revival.

News Image
25 days ago - The Motley Fool

1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell

The stock is high risk, but rewards could be great if all works out well for Novavax.

News Image
25 days ago - The Motley Fool

Is It Too Late to Buy Novavax Stock?

The biotech could fade into irrelevance soon.

News Image
a month ago - The Motley Fool

Where Will Novavax Be in 5 Years?

Can the beaten-down stock turn things around?

News Image
a month ago - The Motley Fool

Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?

Novavax faces a couple of key issues that could be crucial for the stock price.

News Image
a month ago - Market News Video

Novavax Enters Oversold Territory (NVAX)

News Image
a month ago - InvestorPlace

Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold

Be sure to sell these meme stocks as they represent fundamentally weak businesses that will continue to erode in value.

News Image
a month ago - InvestorPlace

Time to Buy These 3 Stocks That Just Hit a 52-Week Low?

Sometimes buying stocks at a 52-week low is a chance to buy a good company at great prices but you need to see if the business is busted.

News Image
a month ago - The Motley Fool

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts

High-water price targets from select analysts imply triple-digit gains in the new year for three former highfliers.

News Image
2 months ago - NOVAVAX, INC

Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will...

News Image
2 months ago - Seeking Alpha

Bank of America favorable on SMID-cap biotechs into 2024

Biotech stocks gain as Bank of America takes a more positive view on SMID-cap stocks and specialty pharma. Read more here.